lilquongohard
26.05.2021 •
Biology
6.The development of antibiotic-resistant M. leprae is inevitable. Researchers are trying to develop antibiotics that would inhibit the biosynthesis of mycolic acids. Would this type of antibiotic be useful to treat M. leprae infections
Solved
Show answers
More tips
- L Leisure and Entertainment How to Make a Crab Trap in Just a Few Minutes...
- H Health and Medicine How Much Does Abortion Cost? Expert Answers and Insights...
- S Sport How to Build Arm Muscles? Effective Exercises and Tips...
- H Health and Medicine When can it be said that a person has a normal pulse?...
- A Art and Culture When Will Eurovision 2011 Take Place?...
- S Style and Beauty How to Choose the Perfect Hair Straightener?...
- F Family and Home Why Having Pets at Home is Good for Your Health...
- H Health and Medicine How to perform artificial respiration?...
- H Health and Medicine 10 Tips for Avoiding Vitamin Deficiency...
- F Food and Cooking How to Properly Cook Buckwheat?...
Answers on questions: Biology
- P Physics An 8-hour exposure to a sound intensity level of 90.0 dB may cause hearing damage. What energy in joules falls on a 0.800-cm-diameter eardrum so exposed?...
- M Mathematics 3 1/6 times 1 4/7 in simplest form...
- B Biology Which of the following resources do goats contribute to society? O ropeO paperO iron O dairy...
Ответ:
explanation below
Explanation:
Leprosy, known as Hansen’s disease, is a chronic infection that is caused by Mycobacterium leprae. This disease damages peripheral nerves and effect areas like skin, yes, muscles and noses. Antibiotics are used to treat the infection between 6 – 12 months. When infected people refuse to follow the treatment schedules given to them by the medical experts, there is usually the development of more antibiotic-resistant M. leprae.
M. leprae, just like tuberculosis, cell walls contain fatty molecules known as mycolic acids, which make the bacteria less susceptible to antibiotics.
Researchers have made remarkable progress in developing drugs such as ethionamide, isoxyl, thiolactomycin, and triclosan that are known to inhibit mycolic acid biosynthesis.
The development of these drugs are part of the tuberculosis drug discovery efforts (in the last one decade) which has been successfully applied to therapeutic targets in the unique mycobacterial wall.
Since morphology and cell wall of M. leprae does not differ remarkably from that of M. tuberculosis, antibiotic developed to inhibit the biosynthesis of mycolic acids would help to treat leprosy
Ответ: